Inactive

The primary objective of this study is to determine the extent to which atorvastatin effectively reduces the incidence and severity of cisplatin-induced hearing loss in patients with head and neck squ... The primary objective of this study is to determine the extent to which atorvastatin effectively reduces the incidence and severity of cisplatin-induced hearing loss in patients with head and neck squamous cell carcinoma (HNSCC).